Across the past 12 months, open-market trades by Protagenic Therapeutics insiders were all purchases, totaling $19,612 (51.9K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Garo H Armen | Exec. Chair Principal Off | 73,533 | 0 | 73,533 | 95.7% | 24 Aug, 2026 |
| 2 | Alexander K. Arrow | Chief Financial Officer | 3,273 | 0 | 3,273 | 4.3% | 13 Oct, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 21 Aug, 2026 | Garo H Armen | Exec. Chair Principal Off | Acquired P | 20,000 | $0.65 | $13.00K | 73,533 | Direct |
| 19 Aug, 2026 | Garo H Armen | Exec. Chair Principal Off | Acquired P | 2,700 | $0.35 | $945 | 36,899 | Direct |
| 11 Aug, 2026 | Garo H Armen | Exec. Chair Principal Off | Acquired P | 2,220 | $0.32 | $710 | 34,199 | Direct |
| 06 Aug, 2026 | Garo H Armen | Exec. Chair Principal Off | Acquired P | 685 | $0.22 | $151 | 31,979 | Direct |
| 30 Jul, 2026 | Garo H Armen | Exec. Chair Principal Off. | Acquired P | 26,291 | $0.18 | $4.81K | 26,291 | Direct |
| 25 Mar, 2024 | Timothy R Wright | Director | Acquired A | 21,250 | $24.36 | $517.64K | 1,518 | Direct |
| 25 Mar, 2024 | Garo H Armen | Executive Chairman | Acquired A | 250,000 | $24.36 | $6.09Mn | 17,858 | Direct |
| 25 Mar, 2024 | Jennifer Buell | Director | Acquired A | 75,000 | $24.36 | $1.83Mn | 5,357 | Direct |
| 25 Mar, 2024 | Khalil Barrage | Director | Acquired A | 22,500 | $24.36 | $548.09K | 1,607 | Direct |
| 25 Mar, 2024 | Alexander K. Arrow | Chief Financial Officer | Acquired A | 100,000 | $24.36 | $2.44Mn | 7,143 | Direct |
| 25 Mar, 2024 | Robert Benjamin Stein | Director | Acquired A | 75,000 | $24.36 | $1.83Mn | 5,357 | Direct |
| 25 Mar, 2024 | Brian Corvese | Director | Acquired A | 43,750 | $24.36 | $1.07Mn | 3,125 | Direct |
| 12 Oct, 2023 | Alexander K. Arrow | Chief Financial Officer | Acquired P | 8,000 | $11.34 | $90.72K | 3,273 | Direct |
| 17 May, 2022 | Alexander K. Arrow | Chief Financial Officer | Acquired P | 23,000 | $39.76 | $914.46K | 2,558 | Direct |
| 18 May, 2022 | Alexander K. Arrow | Chief Financial Officer | Acquired P | 8,000 | $40.32 | $322.55K | 2,701 | Direct |
| 02 Jun, 2021 | Alexander K. Arrow | Chief Financial Officer | Acquired P | 100 | $21.28 | $2.13K | 591 | Direct |
| 03 Jun, 2021 | Alexander K. Arrow | Chief Financial Officer | Acquired P | 16,900 | $21.28 | $359.63K | 893 | Direct |
| 27 May, 2021 | Alexander K. Arrow | Chief Financial Officer | Acquired P | 3,000 | $21.28 | $63.84K | 589 | Direct |
| 26 May, 2021 | Khalil Barrage | Director | Acquired A | 180,000 | $0.00 | $0 | 3,214 | Direct |
| 18 May, 2021 | Alexander K. Arrow | Chief Financial Officer | Acquired P | 12,000 | $17.92 | $215.04K | 214 | Direct |